Diabetes Care, Vol 19, Issue 6 638-641, Copyright © 1996 by American Diabetes Association

ARTICLES

Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases

EJ Goldstein, DM Citron and CA Nesbit
R.M. Alden Research Laboratory, Santa Monica Hospital Medical Center, California 90404, USA. ejegmd@aol.com

OBJECTIVE: To study the relative frequency of bacterial isolates cultured from community-acquired foot infections and assess their comparative in vitro susceptibility to sparfloxacin, levofloxacin, and eight other commonly used oral antimicrobial agents. RESEARCH DESIGN AND METHODS: This is a prospective study in which the infected wounds of 25 consecutive diabetic patients seen by one of the authors were cultured as they entered the hospital. Isolates were stored and tested for susceptibility to 10 oral antimicrobial agents using the agar dilution method. RESULTS: Staphylococcus aurcus was the most common isolate (76% of patients), including methicillin-resistant S. aurcus (MRSA) in 5 of 25 (20%) patient wounds. Streptococci, enterococci, Enterobacteriaceae, and anaerobes were also present in > or = 40% of patient wounds. Sparfloxacin and levofloxacin were the most active agents tested with activity against > or = 88% of isolates. Isolates resistant to sparfloxacin and levofloxacin included MRSA, enterococci, and some anaerobes. When analyzed by prior exposure to antibiotics, patients who had previously received oral antibiotics were more likely to have MRSA, enterococci, and Pseudomonas aeruginosa isolated and less likely to have Enterobacteriaceae and anaerobes isolated from their wounds. CONCLUSIONS: MRSA and enterococci are now a common cause of diabetic foot infections, and the increased prevalence may be due to antimicrobial use. These wounds may require use of combined antimicrobial therapy for initial outpatient management. The new fluoroquinolones, sparfloxacin and levofloxacin, were the most active oral agents tested.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M.P. Khanolkar, S.C. Bain, and J.W. Stephens The diabetic foot QJM, March 18, 2008; (2008) hcn027v1. [Abstract] [Full Text] [PDF]

				E. J. C. Goldstein, D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. T. Fernandez In Vitro Activities of Doripenem and Six Comparator Drugs against 423 Aerobic and Anaerobic Bacterial Isolates from Infected Diabetic Foot Wounds Antimicrob. Agents Chemother., February 1, 2008; 52(2): 761 - 766. [Abstract] [Full Text] [PDF]

				B. A. Lipsky, P. Giordano, S. Choudhri, and J. Song Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate J. Antimicrob. Chemother., August 1, 2007; 60(2): 370 - 376. [Abstract] [Full Text] [PDF]

				E. J. C. Goldstein, D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. T. Fernandez In Vitro Activity of Ceftobiprole against Aerobic and Anaerobic Strains Isolated from Diabetic Foot Infections Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3959 - 3962. [Abstract] [Full Text] [PDF]

				E. J. C. Goldstein, D. M. Citron, Y. A. Warren, K. L. Tyrrell, C. V. Merriam, and H. T. Fernandez In Vitro Activities of Dalbavancin and 12 Other Agents against 329 Aerobic and Anaerobic Gram-Positive Isolates Recovered from Diabetic Foot Infections. Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2875 - 2879. [Abstract] [Full Text] [PDF]

				R. Gadepalli, B. Dhawan, V. Sreenivas, A. Kapil, A.C. Ammini, and R. Chaudhry A Clinico-microbiological Study of Diabetic Foot Ulcers in an Indian Tertiary Care Hospital Diabetes Care, August 1, 2006; 29(8): 1727 - 1732. [Abstract] [Full Text] [PDF]

				B. A. Lipsky, A. R. Berendt, H. G. Deery, J. M. Embil, W. S. Joseph, A. W. Karchmer, J. L. LeFrock, D. P. Lew, J. T. Mader, C. Norden, et al. Diagnosis and Treatment of Diabetic Foot Infections J Am Podiatr Med Assoc, March 1, 2005; 95(2): 183 - 210. [Full Text] [PDF]